Mechanical Function and Gene Expression of α1-Adrenoceptor Subtypes in Dog Intravesical Ureter

Urology

Volumn 74, Issue 2, 2009, Pages 458-462

  Kobayashi, Shinya ^a   Tomiyama, Yoshitaka ^a   Hoyano, Yuji ^a   Yamazaki, Yoshinobu ^a   Kusama, Hiroshi ^a   Kubota, Yasue ^b   Sasaki, Shoichi ^b   Kohri, Kenjiro ^b  

^a Kissei Pharmaceutical Company Limited   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; MESSENGER RNA; NAFTOPIDIL; PHENYLEPHRINE; PRAZOSIN; SILODOSIN;

ANIMAL TISSUE; ARTICLE; DOG; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENCY; GENE EXPRESSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; URETER;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; MALE; MUSCLE CONTRACTION; PHENYLEPHRINE; PRAZOSIN; RECEPTORS, ADRENERGIC, ALPHA-1; URETER;

EID: 67651115723     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.01.009     Document Type: Article

References (18)

1. Pak C.Y. Kidney stones. Lancet 351 (1998) 1797-1801
2. Carstensen H.E., and Hansen J.S. Stones in the ureter. Acta Chir Scand Suppl 433 (1973) 66
3. Morita T., Ando M., Kihara K., et al. Function and distribution of autonomic receptors in canine ureteral smooth muscle. Neurourol Urodyn 13 (1994) 315-321
4. Healy K.A., and Ogan K. Nonsurgical management of urolithiasis: an overview of expulsive therapy. J Endourol 19 (2005) 759-767
5. Küpeli B., Irkilata L., Gürocak S., et al. Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy?. Urology 64 (2004) 1111-1115
6. Ukhal M, Malomuzh O, Strashny V. Administration of doxazosin for speedy elimination of stones from lower part of ureter. Presented at the XIV Congress of the European Association of Urology, Stockholm, Sweden, 1999.
7. Parsons J.K., Hergan L.A., Sakamoto K., et al. Efficacy of α-blockers for the treatment of ureteral stones. J Urol 177 (2007) 983-987
8. Itoh Y., Kojima Y., Yasui T., et al. Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol 14 (2007) 749-753
9. 1-adrenoceptor subtypes in the human ureter. Neurourol Urodyn 24 (2005) 142-148
10. Tomiyama Y., Kobayashi K., Tadachi M., et al. Expressions and mechanical functions of alpha(1)-adrenoceptor subtypes in hamster ureter. Eur J Pharmacol 573 (2007) 201-205
11. Sasaki S., Itoh Y., Kojima Y., et al. Expression level and role in ureteral contraction of alpha1-adrenoceptor subtypes in human ureter. J Urol 179 suppl (2008) 559
12. Hernández M., Prieto D., Simonsen U., et al. Noradrenaline modulates smooth muscle activity of the isolated intravesical ureter of the pig through different types of adrenoceptors. Br J Pharmacol 107 (1992) 924-931
13. Tatemichi S., Tomiyama Y., Maruyama I., et al. Uroselectivity in male dogs of silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia. Neurourol Urodyn 25 (2006) 792-799
14. Goetz A.S., King H.K., Ward S.D., et al. BMY 7378 is a selective antagonist of the D subtype of alpha 1-adrenoceptors. Eur J Pharmacol 272 (1995) R5-R6
15. 1-adrenoceptor antagonist, in human prostate and vasculature. J Urol 164 (2000) 578-583
16. 1A-AR subtypes. Mol Pharmacol 61 (2002) 1008-1016
17. Tomiyama Y., Murakami M., Akiyama K., et al. Modification of ureteral motility and promotion of urine flow around an intraureteral obstruction by CL-316243, phenylephrine, and furosemide in dogs. Neurourol Urodyn 21 (2002) 251-257
18. Morita T., Wada I., Suzuki T., et al. Characterization of α-adrenoceptor subtypes involved in regulation of ureteral fluid transport. Tohoku J Exp Med 152 (1987) 111-118